Direkt zum Inhalt
Merck
  • The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel.

The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel.

Biomaterials (2015-08-04)
Bhushan P Mahadik, Sara Pedron Haba, Luke J Skertich, Brendan A C Harley
ZUSAMMENFASSUNG

Hematopoietic stem cells (HSCs) are a rare stem cell population found primarily in the bone marrow and responsible for the production of the body's full complement of blood and immune cells. Used clinically to treat a range of hematopoietic disorders, there is a significant need to identify approaches to selectively expand their numbers ex vivo. Here we describe a methacrylamide-functionalized gelatin (GelMA) hydrogel for in vitro culture of primary murine HSCs. Stem cell factor (SCF) is a critical biomolecular component of native HSC niches in vivo and is used in large dosages in cell culture media for HSC expansion in vitro. We report a photochemistry based approach to covalently immobilize SCF within GelMA hydrogels via acrylate-functionalized polyethylene glycol (PEG) tethers. PEG-functionalized SCF retains the native bioactivity of SCF but can be stably incorporated and retained within the GelMA hydrogel over 7 days. Freshly-isolated murine HSCs cultured in GelMA hydrogels containing covalently-immobilized SCF showed reduced proliferation and improved selectivity for maintaining primitive HSCs. Comparatively, soluble SCF within the GelMA hydrogel network induced increased proliferation of differentiating hematopoietic cells. We used a microfluidic templating approach to create GelMA hydrogels containing gradients of immobilized SCF that locally direct HSC response. Together, we report a biomaterial platform to examine the effect of the local presentation of soluble vs. matrix-immobilized biomolecular signals on HSC expansion and lineage specification. This approach may be a critical component of a biomaterial-based artificial bone marrow to provide the correct sequence of niche signals to grow HSCs in the laboratory.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
N-Hydroxysuccinimid, 98%
Sigma-Aldrich
Methacrylsäureanhydrid, contains 2,000 ppm topanol A as inhibitor, ≥94%
Sigma-Aldrich
Natriumazid, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Fluoreszein-5(6)-isothiocyanat, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
Natriumazid, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Natriumazid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
2-Butanon, FCC, FG
Sigma-Aldrich
Fluoreszein-5(6)-isothiocyanat, ≥90% (HPLC)
Sigma-Aldrich
Methyl-diethoxysilan, ≥96%
Sigma-Aldrich
Fluorescein-Isothiocyanat Isomer I, ≥97.5% (HPLC)
Sigma-Aldrich
Natriumazid, BioXtra
Sigma-Aldrich
Lithiumbromid, powder and chunks, ≥99.995% trace metals basis
Sigma-Aldrich
Lithiumbromid, AnhydroBeads, −10 mesh, 99.999% trace metals basis
Sigma-Aldrich
2,4,6-Trimethylbenzoylchlorid, 97%
Sigma-Aldrich
Dimethylphenylphosphonit, 97%
Sigma-Aldrich
Lithiumbromid, AnhydroBeads, −10 mesh, ≥99.9% trace metals basis